PBK is called PDZ Binding Kinase, and studies have demonstrated that PBK is an effective drug target with multiple therapeutic potentials in a variety of cancers, such as ovarian cancer, prolactinoma, and cervical cancer.18, 19, 20. This evidence concerns the gene PBK and ovarian carcinoma.